Article
29 Jul 2025
GLP-1 Receptor Agonists: Clinical Trial Considerations
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
22 Jul 2025
Episode 36: Let's Talk Compliance: The Risks And Pitfalls Of Health Care Supply Chain Compliance (Podcast)
Article
16 May 2025
Data Transactions: DOJ's Final Rule's Implications For Academic Medical Centers With Clinical Research Programs
Article
24 Apr 2025
Prescription Drugs: Executive Order Aims To Lower Prices
Article
05 Apr 2025
Texas Court Vacates FDA's Laboratory Developed Test (LDT) Final Rule
Article
07 Feb 2025
FDA & OHRP Draft Guidance: Including Tissue Biopsies In Clinical Trials
Article
17 Dec 2024
Antibody Drug Conjugates Keep Growing: What You Need To Know
Article
21 Nov 2024
FDA Clinical Investigations: New Guidance On Electronic Systems
Article
14 Nov 2024
Key Takeaways From TEDAI 2024
Article
08 Nov 2024
Cancer Drugs: Clinical Trial Issues For Antibody Drug Conjugates (ADCs)/Antibody Therapeutics
Article
02 Oct 2024
Decentralized Clinical Trials: Research Misconduct Risks & How To Avoid Them
Article
26 Sep 2024
Research Misconduct: ORI Issues Final Rule With Modernized And Streamlined Regulations
Article
26 Jul 2024
Clinical Trials: FDA Publishes Draft Guidance On Diversity Action Plans
Article
09 May 2024
2024 Health Care & Life Sciences Top Trends - Driving Tomorrow's Advances In The Health Care And Life Sciences Ecosystems
Article
06 Mar 2024
OIG Opines On Subsidizing Medicare Cost-Sharing For Clinical Trials
Article
13 Dec 2023
Decentralized Clinical Trials: Diversity In Clinical Trials
Article
17 Oct 2023
ORI Proposes New Rulemaking For Research Misconduct Regulations
Article
11 Sep 2023
Clinical Trials: Consent Process Clarified In New FDA Final Guidance
Article
07 Sep 2023
Decentralized Clinical Trials: Sponsor Responsibilities
Article
28 Jul 2023
Decentralized Clinical Trials: Investigator Responsibilities